Dr. Ciarán Kelly Joins Newly Formed Synthetic Biologics Clinical Advisory Board

Gastroenterology and Endoscopy

Share on Facebook
Synthetic Biologics, a biologics and drug developer, has formed a clinical advisory board to support the development of SYN-004, an anti-infective product for the prevention of Clostridium difficile infections.

Ciarán Kelly, MD, a professor of medicine at Harvard Medical School, has joined the new clinical advisory board. Dr. Kelly is the director of the gastroenterology fellowship training program and medical director of the Celiac Center at Beth Israel Deaconess Medical Center in Boston.

The clinical advisory board also includes:

•    Mark Wilcox, MD, head of microbiology at Leeds Teaching Hospital in the United Kingdom
•    Curtis Donskey, MD, an associate professor of medicine at Case Western Reserve University School of Medicine in Cleveland
•    Thomas Louie, MD, a professor of medicine at the University of Calgary in Alberta, Canada  

More Articles on Gastroenterology:
American Board of Surgery to Require Standardized Endoscopy Training
8 Devices & Tests Designed to Improve Colorectal Cancer Screening
The Good, the Bad & the Ugly: The Economics of GI

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New from Becker's ASC Review

How has healthcare reform affected gastroenterology?

Read Now